Additionally, our own database analysis and several published reports have demonstrated high JAK1 amounts and activity in tumors, rendering JAK1 as a promising biomarker that correlates with clinicopathological characteristics within specific cancer types, for example, in breast cancer [72]. This evidence concerns the gene JAK1 and breast cancer.